On February 18, we have invited Dr. Tero-Pekka Alastalo, to give a talk about his experience with co-founding the precision medicine company Blueprint Genetics in 2012. What started out as a technology development spinout from Stanford University, quickly grew to a global genetic testing company with >200 employees (acquired by Quest Diagnostics in 2020). With […]

On March 18, Uppsala University Associate Professor Sara Mangsbo will talk about how the future of cancer therapy is becoming personal. Sara co-founded Strike Pharma to further develop the Uppsala University and SciLifeLab Drug Discovery platform co-developed ADAC technology (Adaptable Drug Affinity Conjugates). With current diagnostic tools also, immunotherapy can and should enter the omics-field and the developed […]

On April 8, Dr. Jean-Marie Volland, Scientist at Berkeley Lab and Laboratory for Research in Complex Systems (LRC Systems), and Shailesh Date, CEO of LRC Systems (Adj. Assoc. Professor at UCSF),will talk about their recent discovery and characterization of the macro-bacteria Ca. Thiomargarita magnifica. The threadlike single-cell bacterium, commonly found in the Caribbean Mangroves, is […]

Dr. Sami Blom leads Aiforia’s application development team with an ambition to build impactful image analysis solutions to advance histopathology. He has a background in the fields of translational cancer research and pathology and he has extensive expertise in staining and imaging methods for histology specimens. Dr. Blom joined Aiforia in 2016 to develop and […]

On May 6, Professor Tomi Mäkelä at the University of Helsinki Faculty of Medicine will talk about his work as executive officer of the iCAN Digital Precision Cancer Medicine flagship. iCAN is one of the Academy of Finland national research and innovation flagships for 2019-2026, with the goal to develop a nucleus of scientific excellence […]